An integrative, multi-omics approach towards the prioritization of Klebsiella pneumoniae drug targets
Klebsiella pneumoniae (Kp) is a globally disseminated opportunistic pathogen that can cause life-threatening infections. It has been found as the culprit of many infection outbreaks in hospital environments, being particularly aggressive towards newborns and adults under intensive care. Many Kp stra...
Guardado en:
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | JOUR |
| Acceso en línea: | http://hdl.handle.net/20.500.12110/paper_20452322_v8_n1_p_Ramos |
| Aporte de: |
| id |
todo:paper_20452322_v8_n1_p_Ramos |
|---|---|
| record_format |
dspace |
| spelling |
todo:paper_20452322_v8_n1_p_Ramos2023-10-03T16:38:27Z An integrative, multi-omics approach towards the prioritization of Klebsiella pneumoniae drug targets Ramos, P.I.P. Fernández Do Porto, D. Lanzarotti, E. Sosa, E.J. Burguener, G. Pardo, A.M. Klein, C.C. Sagot, M.-F. De Vasconcelos, A.T.R. Gales, A.C. Marti, M. Turjanski, A.G. Nicolás, M.F. Klebsiella pneumoniae (Kp) is a globally disseminated opportunistic pathogen that can cause life-threatening infections. It has been found as the culprit of many infection outbreaks in hospital environments, being particularly aggressive towards newborns and adults under intensive care. Many Kp strains produce extended-spectrum β-lactamases, enzymes that promote resistance against antibiotics used to fight these infections. The presence of other resistance determinants leading to multidrug-resistance also limit therapeutic options, and the use of 'last-resort' drugs, such as polymyxins, is not uncommon. The global emergence and spread of resistant strains underline the need for novel antimicrobials against Kp and related bacterial pathogens. To tackle this great challenge, we generated multiple layers of 'omics' data related to Kp and prioritized proteins that could serve as attractive targets for antimicrobial development. Genomics, transcriptomics, structuromic and metabolic information were integrated in order to prioritize candidate targets, and this data compendium is freely available as a web server. Twenty-nine proteins with desirable characteristics from a drug development perspective were shortlisted, which participate in important processes such as lipid synthesis, cofactor production, and core metabolism. Collectively, our results point towards novel targets for the control of Kp and related bacterial pathogens. © 2018 The Author(s). JOUR info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/2.5/ar http://hdl.handle.net/20.500.12110/paper_20452322_v8_n1_p_Ramos |
| institution |
Universidad de Buenos Aires |
| institution_str |
I-28 |
| repository_str |
R-134 |
| collection |
Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA) |
| description |
Klebsiella pneumoniae (Kp) is a globally disseminated opportunistic pathogen that can cause life-threatening infections. It has been found as the culprit of many infection outbreaks in hospital environments, being particularly aggressive towards newborns and adults under intensive care. Many Kp strains produce extended-spectrum β-lactamases, enzymes that promote resistance against antibiotics used to fight these infections. The presence of other resistance determinants leading to multidrug-resistance also limit therapeutic options, and the use of 'last-resort' drugs, such as polymyxins, is not uncommon. The global emergence and spread of resistant strains underline the need for novel antimicrobials against Kp and related bacterial pathogens. To tackle this great challenge, we generated multiple layers of 'omics' data related to Kp and prioritized proteins that could serve as attractive targets for antimicrobial development. Genomics, transcriptomics, structuromic and metabolic information were integrated in order to prioritize candidate targets, and this data compendium is freely available as a web server. Twenty-nine proteins with desirable characteristics from a drug development perspective were shortlisted, which participate in important processes such as lipid synthesis, cofactor production, and core metabolism. Collectively, our results point towards novel targets for the control of Kp and related bacterial pathogens. © 2018 The Author(s). |
| format |
JOUR |
| author |
Ramos, P.I.P. Fernández Do Porto, D. Lanzarotti, E. Sosa, E.J. Burguener, G. Pardo, A.M. Klein, C.C. Sagot, M.-F. De Vasconcelos, A.T.R. Gales, A.C. Marti, M. Turjanski, A.G. Nicolás, M.F. |
| spellingShingle |
Ramos, P.I.P. Fernández Do Porto, D. Lanzarotti, E. Sosa, E.J. Burguener, G. Pardo, A.M. Klein, C.C. Sagot, M.-F. De Vasconcelos, A.T.R. Gales, A.C. Marti, M. Turjanski, A.G. Nicolás, M.F. An integrative, multi-omics approach towards the prioritization of Klebsiella pneumoniae drug targets |
| author_facet |
Ramos, P.I.P. Fernández Do Porto, D. Lanzarotti, E. Sosa, E.J. Burguener, G. Pardo, A.M. Klein, C.C. Sagot, M.-F. De Vasconcelos, A.T.R. Gales, A.C. Marti, M. Turjanski, A.G. Nicolás, M.F. |
| author_sort |
Ramos, P.I.P. |
| title |
An integrative, multi-omics approach towards the prioritization of Klebsiella pneumoniae drug targets |
| title_short |
An integrative, multi-omics approach towards the prioritization of Klebsiella pneumoniae drug targets |
| title_full |
An integrative, multi-omics approach towards the prioritization of Klebsiella pneumoniae drug targets |
| title_fullStr |
An integrative, multi-omics approach towards the prioritization of Klebsiella pneumoniae drug targets |
| title_full_unstemmed |
An integrative, multi-omics approach towards the prioritization of Klebsiella pneumoniae drug targets |
| title_sort |
integrative, multi-omics approach towards the prioritization of klebsiella pneumoniae drug targets |
| url |
http://hdl.handle.net/20.500.12110/paper_20452322_v8_n1_p_Ramos |
| work_keys_str_mv |
AT ramospip anintegrativemultiomicsapproachtowardstheprioritizationofklebsiellapneumoniaedrugtargets AT fernandezdoportod anintegrativemultiomicsapproachtowardstheprioritizationofklebsiellapneumoniaedrugtargets AT lanzarottie anintegrativemultiomicsapproachtowardstheprioritizationofklebsiellapneumoniaedrugtargets AT sosaej anintegrativemultiomicsapproachtowardstheprioritizationofklebsiellapneumoniaedrugtargets AT burguenerg anintegrativemultiomicsapproachtowardstheprioritizationofklebsiellapneumoniaedrugtargets AT pardoam anintegrativemultiomicsapproachtowardstheprioritizationofklebsiellapneumoniaedrugtargets AT kleincc anintegrativemultiomicsapproachtowardstheprioritizationofklebsiellapneumoniaedrugtargets AT sagotmf anintegrativemultiomicsapproachtowardstheprioritizationofklebsiellapneumoniaedrugtargets AT devasconcelosatr anintegrativemultiomicsapproachtowardstheprioritizationofklebsiellapneumoniaedrugtargets AT galesac anintegrativemultiomicsapproachtowardstheprioritizationofklebsiellapneumoniaedrugtargets AT martim anintegrativemultiomicsapproachtowardstheprioritizationofklebsiellapneumoniaedrugtargets AT turjanskiag anintegrativemultiomicsapproachtowardstheprioritizationofklebsiellapneumoniaedrugtargets AT nicolasmf anintegrativemultiomicsapproachtowardstheprioritizationofklebsiellapneumoniaedrugtargets AT ramospip integrativemultiomicsapproachtowardstheprioritizationofklebsiellapneumoniaedrugtargets AT fernandezdoportod integrativemultiomicsapproachtowardstheprioritizationofklebsiellapneumoniaedrugtargets AT lanzarottie integrativemultiomicsapproachtowardstheprioritizationofklebsiellapneumoniaedrugtargets AT sosaej integrativemultiomicsapproachtowardstheprioritizationofklebsiellapneumoniaedrugtargets AT burguenerg integrativemultiomicsapproachtowardstheprioritizationofklebsiellapneumoniaedrugtargets AT pardoam integrativemultiomicsapproachtowardstheprioritizationofklebsiellapneumoniaedrugtargets AT kleincc integrativemultiomicsapproachtowardstheprioritizationofklebsiellapneumoniaedrugtargets AT sagotmf integrativemultiomicsapproachtowardstheprioritizationofklebsiellapneumoniaedrugtargets AT devasconcelosatr integrativemultiomicsapproachtowardstheprioritizationofklebsiellapneumoniaedrugtargets AT galesac integrativemultiomicsapproachtowardstheprioritizationofklebsiellapneumoniaedrugtargets AT martim integrativemultiomicsapproachtowardstheprioritizationofklebsiellapneumoniaedrugtargets AT turjanskiag integrativemultiomicsapproachtowardstheprioritizationofklebsiellapneumoniaedrugtargets AT nicolasmf integrativemultiomicsapproachtowardstheprioritizationofklebsiellapneumoniaedrugtargets |
| _version_ |
1807321883850309632 |